Literature DB >> 11383843

The use of adenosine for repair of penetrating cardiac injuries: a novel method.

R Lim1, I S Gill, R T Temes, C E Smith.   

Abstract

The use of intravenous administration of adenosine to expedite cardiorrhaphy in penetrating cardiac trauma by inducing temporary asystole is described. It is quicker, more effective, and safer than the traditional methods.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11383843     DOI: 10.1016/s0003-4975(01)02457-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Penetrating nail-gun injury of the heart managed by adenosine-induced asystole in the absence of a heart-lung machine.

Authors:  Holger Rupprecht; Marius Ghidau
Journal:  Tex Heart Inst J       Date:  2014-08-01

2.  Penetrating cardiac injury repaired under "intentional cardiac arrest" with adenosine triphosphate.

Authors:  Kazuki Hagiwara; Jun-Ichi Inoue; Gaku Matumoto; Fumiaki Iwase
Journal:  Acute Med Surg       Date:  2021-08-07

3.  Delayed Cardiac Rupture Induced by Traumatic Myocardial Infarction: Consequence of a 45-Magnum Blast Injury; A Comprehensive Case Review.

Authors:  Holger Rupprecht; Katharina Gaab
Journal:  Bull Emerg Trauma       Date:  2018-01

4.  Intravenous adenosine for surgical management of penetrating heart wounds.

Authors:  John Kokotsakis; Panagiotis Hountis; Nikolaos Antonopoulos; Elian Skouteli; Thanos Athanasiou; Achilleas Lioulias
Journal:  Tex Heart Inst J       Date:  2007

5.  Out-of-hospital cardiopulmonary arrest due to penetrating cardiac injury treated by percutaneous cardiopulmonary support in the emergency room: report of a case.

Authors:  Yoshihiko Kurimoto; Hitoshi Kano; Naoya Yama; Satoshi Nara; Mamoru Hase; Yasufumi Asai
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

Review 6.  Management of Peripheral and Truncal Venous Injuries.

Authors:  Triantafillos G Giannakopoulos; Efthymios D Avgerinos
Journal:  Front Surg       Date:  2017-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.